Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.
by Marci A. Landsmann
Vice president cites immunotherapy, big data and team science as innovative ways to speed progress against cancer.
by Kevin McLaughlin
A recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
Does Exercise Benefit Children With Cancer?New guidelines recommend children and adolescents with cancer get regular physical activity to mitigate side effects from treatment.
by Erin O’Donnell
Can the CYP2D6 Gene Affect Tamoxifen’s Effectiveness?A recent analysis examined whether CYP2D6 metabolism influences tamoxifen response. The answer isn’t entirely clear.
by Ashley P. Taylor
The AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
The AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
